Sales of 355.091 billion won, net profit of 47.309 billion won

Daewoong Pharmaceutical announced on November 7 that, based on its provisional third-quarter results for this year, operating profit reached 53.527 billion won, marking a 30.1% increase compared to the same period last year.

Daewoong Pharmaceutical, Gangnam-gu, Seoul. Photo by Yonhap News Agency

Daewoong Pharmaceutical, Gangnam-gu, Seoul. Photo by Yonhap News Agency

View original image

During the same period, sales amounted to 355.091 billion won and net profit was 43.091 billion won, up by 12.4% and 34.89%, respectively.


On a consolidated basis, third-quarter sales were recorded at 411.832 billion won, operating profit at 56.893 billion won, and net profit at 47.309 billion won.



Cumulative sales for the first three quarters of this year reached 1.035175 trillion won.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing